The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-6.7% to $305.00
Predicted High$345.00at 3 months
Predicted Low$305.00at 6 months
Max Drawdown (predicted)-6.7%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 21, 2026 1:05 pm
Bear
NTRA trends lower to
$305.00
(-6.7% from $326.89)
by Feb 2027.
ride-then-fade
ThesisNTRA rides strong sentiment, blowout Q2, and Druckenmiller endorsement momentum near-term, but stretched valuation (attractive only below $240) and negative value/quality lenses create gravity. Expect a modest melt-up into fall, then drift as narrative digests, with no catalyst to break higher absent next print.
Invalidated ifBreak below $290 on volume, or a sector-wide diagnostics selloff, or negative payer/CMS headline invalidates the momentum leg.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $326.89 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 21, 2026
—
$326.89at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 4, 2026
$290.54–$363.24typical range · internal point $335.00
—
±11.1%
7/10
Momentum and sentiment carry continues short-term
1 month
Sep 21, 2026
$274.22–$379.56typical range · internal point $342.00
—
±16.1%
6/10
Narrative peaks, Druckenmiller halo still active
2 months
Oct 21, 2026
$338.00
—
+3.4%
5/10
Consolidation as buyers exhausted pre-earnings
3 months
Nov 21, 2026
$345.00
—
+5.5%
4/10
Q3 print likely beats, brief pop
4 months
Dec 21, 2026
$330.00
—
+1.0%
4/10
Post-earnings fade, tax-loss rotation elsewhere
5 months
Jan 21, 2027
$315.00
—
-3.6%
4/10
Value gravity, quality concerns weigh
6 months
Feb 21, 2027
$305.00
—
-6.7%
3/10
Drift toward fairer range as narrative cools
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.